13D/13G Filings - Crinetics Pharmaceuticals Inc. (CRNX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-02-09
08:50 am
Purchase
2024-02-08 13G Crinetics Pharmaceuticals, Inc.
CRNX
FMR CORP 4,043,865
6.053%
2,160,747increase
(+114.74%)
Filing
History
2024-02-08
10:11 am
Purchase
2023-12-29 13G Crinetics Pharmaceuticals, Inc.
CRNX
WELLINGTON MANAGEMENT CO LLP 3,245,105
4.860%
440,620increase
(+15.71%)
Filing
History
2024-01-25
4:59 pm
Purchase
2023-12-31 13G Crinetics Pharmaceuticals, Inc.
CRNX
BLACKROCK INC
BLK
5,345,114
8.000%
1,427,625increase
(+36.44%)
Filing
History
2024-01-24
10:28 am
Purchase
2023-12-31 13G Crinetics Pharmaceuticals, Inc.
CRNX
STATE STREET CORP
STT
3,563,736
5.340%
3,563,736increase
(New Position)
Filing
History
2023-09-18
4:24 pm
Purchase
2023-09-15 13G Crinetics Pharmaceuticals, Inc.
CRNX
Point72 Asset Management, L.P. 3,727,952
5.600%
3,727,952increase
(New Position)
Filing
History
2023-02-14
4:12 pm
Unchanged
2022-12-31 13G Crinetics Pharmaceuticals, Inc.
CRNX
ORBIMED ADVISORS LLC 3,196,876
5.900%
0
(Unchanged)
Filing
History
2023-02-14
4:06 pm
Purchase
2022-12-31 13G Crinetics Pharmaceuticals, Inc.
CRNX
BRAIDWELL LP 3,469,674
6.450%
3,469,674increase
(New Position)
Filing
History
2023-02-14
11:58 am
Sale
2022-12-31 13G Crinetics Pharmaceuticals, Inc.
CRNX
BIOTECHNOLOGY VALUE FUND L P 2,736,613
5.100%
-267,266decrease
(-8.90%)
Filing
History
2023-02-09
09:59 am
Sale
2023-02-09 13G Crinetics Pharmaceuticals, Inc.
CRNX
FMR CORP 1,883,118
3.499%
-1,839,176decrease
(-49.41%)
Filing
History
2023-02-08
11:32 am
Purchase
2022-12-31 13G Crinetics Pharmaceuticals, Inc.
CRNX
DRIEHAUS CAPITAL MANAGEMENT INC 5,624,744
10.450%
831,106increase
(+17.34%)
Filing
History
2023-02-06
2:51 pm
Purchase
2022-12-30 13G Crinetics Pharmaceuticals, Inc.
CRNX
WELLINGTON MANAGEMENT CO LLP 2,804,485
5.210%
2,804,485increase
(New Position)
Filing
History
2023-01-31
1:58 pm
Purchase
2022-12-31 13G Crinetics Pharmaceuticals, Inc.
CRNX
BLACKROCK INC
BLK
3,917,489
7.300%
641,319increase
(+19.58%)
Filing
History
2022-04-25
7:02 pm
Unchanged
2022-04-25 13D Crinetics Pharmaceuticals, Inc.
CRNX
PERCEPTIVE ADVISORS LLC 5,333,532
10.000%
0
(Unchanged)
Filing
History
2022-04-20
9:17 pm
Purchase
2022-04-18 13D Crinetics Pharmaceuticals, Inc.
CRNX
PERCEPTIVE ADVISORS LLC 5,333,532
10.000%
1,674,151increase
(+45.75%)
Filing
History
2022-02-14
09:08 am
Purchase
2021-12-31 13G Crinetics Pharmaceuticals, Inc.
CRNX
Deep Track Capital, LP 1,900,000
4.000%
1,334increase
(+0.07%)
Filing
History
2022-02-11
5:22 pm
Sale
2021-12-31 13G Crinetics Pharmaceuticals, Inc.
CRNX
Vivo Capital VIII LLC 0
0.000%
-1,819,600decrease
(Position Closed)
Filing
History
2022-02-11
4:19 pm
Purchase
2021-12-31 13G Crinetics Pharmaceuticals, Inc.
CRNX
ORBIMED ADVISORS LLC 3,196,876
6.700%
443,309increase
(+16.10%)
Filing
History
2022-02-10
8:21 pm
Sale
2021-12-31 13G Crinetics Pharmaceuticals, Inc.
CRNX
Versant Venture Capital V L.P. 382,961
0.800%
-1,512,041decrease
(-79.79%)
Filing
History
2022-02-10
4:30 pm
Purchase
2021-12-31 13G Crinetics Pharmaceuticals, Inc.
CRNX
Struthers Richard Scott 1,978,334
4.200%
274,339increase
(+16.10%)
Filing
History
2022-02-03
4:41 pm
Purchase
2021-12-31 13G Crinetics Pharmaceuticals, Inc.
CRNX
BLACKROCK INC
BLK
3,276,170
6.900%
1,162,975increase
(+55.03%)
Filing
History
Goto Prev, 0, 1, 2, Next